Research-backed profiles for 78 popular peptides. Effects, dosing ranges, side effects, regulatory status, and cited studies.
Filter by tag
Gastric pentadecapeptide with broad tissue-healing properties.
Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity.
The 7-amino-acid active fragment of TB-500, isolated for cell-migration effects.
Anti-inflammatory tripeptide derived from alpha-melanocyte stimulating hormone.
Human antimicrobial peptide with broad-spectrum pathogen defense and wound-healing activity.
Tissue-protective helix-B fragment of erythropoietin — without the red-blood-cell effects.
Broad neuropeptide with anti-inflammatory, immunomodulatory, and vasodilatory activity.
Long-acting growth hormone releasing hormone analog for sustained GH and IGF-1 elevation.
Selective growth hormone secretagogue with minimal side effects.
FDA-approved GHRH analog for HIV-associated lipodystrophy with potent GH-releasing activity.
The original GHRH analog and the first FDA-approved peptide secretagogue.
First-generation ghrelin mimetic — potent GH release with notable appetite stimulation.
Refined ghrelin mimetic — stronger GH release than GHRP-6 with less hunger.
The most potent GHRP — strong GH release with documented cardioprotective signaling.
A locally-acting IGF-1 splice variant released by muscle in response to mechanical load.
Soluble myostatin / activin trap — recombinant decoy of the activin IIB receptor.
Endogenous activin/myostatin binding protein — the gene-therapy myostatin inhibitor.
Short-peptide myostatin inhibitor targeting the GDF-8 / activin RIIB pathway.
Long-acting IGF-1 analog with reduced binding-protein affinity for sustained signaling.
Truncated IGF-1 variant — site-specific, short-acting muscle growth signal.
Single-chain relaxin peptide analog with anti-fibrotic and cardioprotective activity.
GLP-1 receptor agonist revolutionizing the treatment of obesity and type 2 diabetes.
Dual GIP/GLP-1 receptor agonist delivering unprecedented weight loss and metabolic benefits.
Lilly's triple-agonist of GLP-1, GIP, and glucagon receptors — the strongest weight-loss data yet reported.
Dual GLP-1 / glucagon receptor agonist in late-stage obesity trials.
Fat-metabolizing fragment of human growth hormone without growth-promoting effects.
The unmodified C-terminal fragment of growth hormone — the original lipolytic peptide.
Vasculature-targeting peptide that selectively destroys adipose blood vessels.
Russian-approved anxiolytic peptide derived from tuftsin with nootropic and immunomodulatory properties.
Neuroprotective ACTH analog with nootropic and neurotrophic properties.
Neuroprotective tripeptide bioregulator that penetrates the nuclear membrane to directly regulate gene expression in brain tissue.
Adamantyl-capped Semax derivative — a more lipophilic, longer-acting nootropic analog.
Hybrid Humanin / ADNF peptide — high-potency neuroprotective agent for Alzheimer's research.
Hepatocyte growth factor mimetic — claimed to be 7 orders of magnitude more potent than BDNF.
Eleven-amino-acid peptide derived from the GDNF prodomain — neuroprotective for dopamine neurons.
Neurogenic, anti-tau peptide derived from ciliary neurotrophic factor — Alzheimer's research.
Fast-acting antidepressant peptide acting via TREK-1 channel inhibition.
Full-length adrenocorticotropic hormone — endocrine research peptide, melanocortin agonist.
Thymic peptide with broad immunomodulatory activity, approved in over 35 countries.
Russian-approved 14-amino-acid immunomodulator derived from the ezrin protein.
Mitochondrial-derived peptide that mimics exercise and regulates metabolic homeostasis.
Mitochondria-targeted tetrapeptide that restores bioenergetics by stabilizing cardiolipin.
Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production.
D-retro-inverso senolytic peptide — selectively kills senescent cells via FOXO4-p53 disruption.
Acetylated Epitalon variant — more stable, longer-acting form of the telomerase-activating tetrapeptide.
Central cellular cofactor — supplemented to support mitochondrial function and sirtuin activity.
Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties.
Synthetic melanocortin peptide with tanning, appetite-suppressive, and sexual function effects.
Palmitoyl pentapeptide that signals fibroblasts to rebuild collagen and elastin.
Eight-amino-acid SNARE-blocking peptide — topical "botox-alternative" for expression lines.
Lipophilic GHK derivative — collagen-stimulating tripeptide for topical anti-aging.
Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent.
FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder.
The "bonding hormone" — neuropeptide with established obstetric and exploratory social roles.
Master upstream regulator of the reproductive axis — the GnRH releaser.
Long-acting GnRH agonist — FDA-approved for prostate cancer and used in PCT protocols.
Endogenous nonapeptide that promotes delta wave sleep and modulates neuroendocrine stress responses.
Hypothalamic wake-promoting neuropeptide — the molecule lost in narcolepsy type 1.
Wake-promoting neuropeptide selective for OX2R — the receptor most central to narcolepsy.
Khavinson short peptide bioregulator targeting bronchial epithelium and lung tissue.
Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium.
Khavinson short peptide bioregulator targeting chondrocytes and connective tissue.
Khavinson short peptide bioregulator targeting cortical neurons and CNS gene expression.
Khavinson short peptide bioregulator targeting thymus / immune cells.
Khavinson short peptide bioregulator targeting hepatocytes and liver function.
Khavinson short peptide bioregulator targeting pancreatic tissue and glucose metabolism.
Khavinson short peptide bioregulator targeting prostate tissue.
Khavinson short peptide bioregulator targeting testicular tissue.
Khavinson short peptide bioregulator targeting thymic function — Glu-Trp synthetic version.
Original Khavinson thymic peptide complex — multi-peptide immunomodulator with 40-year Russian clinical track record.
Khavinson short peptide bioregulator targeting urinary bladder epithelium.
Khavinson short peptide bioregulator targeting vascular endothelium — KED tripeptide.
Khavinson Lys-Glu dipeptide — immunomodulator with documented life-extension activity in mice.
Membrane-active anticancer research peptide — selectively lyses cancer cell membranes.
Naturally occurring μ-opioid receptor agonist ~30-40× more potent than morphine — research-only.
The classic recovery stack — BPC-157 paired with TB-500 for accelerated tissue repair.
Wolverine's healing duo plus GHK-Cu — soft-tissue recovery with a cosmetic kicker for skin, hair, and scars.
Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial.
280 side-by-side comparisons covering effects, dosing, side effects, and reconstitution.
Manage your peptide stack with dose tracking, injection site rotation, and more.
Get Started Free